CLINICAL_TRIALS
research
· 2026-04-22
Clinical Trial Update: Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susceptible Pulmonary Tuberculosis [Phase 2]
Summary
A Phase 2 study is assessing bactericidal activity and safety of adding nicotinamide to bedaquiline, pretomanid, and linezolid for drug-susceptible pulmonary tu…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gates Medical Research Institute | Conditions: Drug Susceptible Pulmonary Tuberculosis | Phase 2 | Status: RECRUITING